Milsaperidone is an active metabolite of iloperidone

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

Teens who use weed are twice as likely to develop psychotic or bipolar disorders, a new study says. They also are more likely to have depression and anxiety, researchers reported Feb. 20 in JAMA Health Forum.

Pop star Mariah Carey revealed her “struggles” with bipolar II disorder, after almost two decades of silence.

Milsaperidone, a new chemical entity, is the major active metabolite of iloperidone (Fanapt) and had been demonstrated to be bioequivalent to iloperidone.

NPR's Scott Detrow talks with music journalist and mental health advocate Kiana Fitzgerald about the latest public apology from the artist formerly known as Kanye West.

Adolescents who use cannabis could face a significantly higher risk of developing serious psychiatric disorders by young adulthood, according to a large study published in JAMA Health Forum. The longitudinal study followed 463,